Patent ID: 8802702

Claim:
A method of reducing drug resistance in a subject undergoing cancer treatment with administration of a chemotherapeutic drug, wherein the cancer is selected from the group consisting of: breast, respiratory tract, brain, reproductive organs, digestive tract, urinary tract, eye, liver, head and neck, thyroid, parathyroid, a distant metastasis of a solid tumor, lymphoma, sarcoma, and leukemia, said method comprising administering to a subject in need thereof an effective amount of (2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol or a pharmaceutically acceptable salt thereof, wherein (2-(4-methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol or a pharmaceutically acceptable salt thereof is administered at a dose that is lower than the dose required to produce cytotoxicity in said subject, thereby reducing drug resistance in said subject.